Identifying sex-specific differences in the carotid revascularisation literature: findings from a scoping review.


Journal

Stroke and vascular neurology
ISSN: 2059-8696
Titre abrégé: Stroke Vasc Neurol
Pays: England
ID NLM: 101689996

Informations de publication

Date de publication:
09 2021
Historique:
received: 09 11 2020
revised: 09 12 2020
accepted: 02 01 2021
pubmed: 31 3 2021
medline: 6 4 2022
entrez: 30 3 2021
Statut: ppublish

Résumé

No systematic review of the literature has dedicated itself to looking at the management of symptomatic carotid stenosis in female patients. In this scoping review, we aimed to identify all randomised controlled trials (RCTs) that reported sex-specific outcomes for patients who underwent carotid revascularisation, and determine whether sufficient information is reported within these studies to assess short-term and long-term outcomes in female patients. We systematically searched Medline, Embase, Pubmed and Cochrane libraries for RCTs published between 1991 and 2020 that included female patients and compared either endarterectomy with stenting, or any revascularisation (endarterectomy or stenting) with medical therapy in patients with symptomatic high-grade (>50%) carotid stenosis. From 1537 references examined, 27 eligible studies were identified. Sex-specific outcomes were reported in 13 studies. Baseline patient characteristics of enrolled female patients were reported in 2 of those 13 studies. Common outcomes reported included stroke and death, however, there was significant heterogeneity in the reporting of both periprocedural and long-term outcomes. Sex-specific differences relating to the degree of stenosis and time from index event to treatment are largely limited to studies comparing endarterectomy to medical therapy. Adverse events were not reported by sex. Only half of the previously published RCTs and systematic reviews report sex-specific outcomes. Detailed analyses on the results of carotid artery intervention for female patients with symptomatic stenosis are limited.

Identifiants

pubmed: 33782196
pii: svn-2020-000744
doi: 10.1136/svn-2020-000744
pmc: PMC8485244
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

496-499

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet Neurol. 2011 Jun;10(6):530-7
pubmed: 21550314
Lancet Neurol. 2011 Jun;10(6):494-7
pubmed: 21550315
Lancet. 2005 Jan 8-14;365(9454):176-86
pubmed: 15639301
Stroke. 2005 Jan;36(1):27-31
pubmed: 15569876
Lancet. 2010 Mar 20;375(9719):985-97
pubmed: 20189239
Lancet Neurol. 2009 Oct;8(10):898-907
pubmed: 19717345
Lancet. 2006 Oct 7;368(9543):1239-47
pubmed: 17027729
Lancet. 2004 Mar 20;363(9413):915-24
pubmed: 15043958
Stroke Vasc Neurol. 2016 Dec 19;1(4):192-196
pubmed: 28959483
J Clin Epidemiol. 2018 May;97:126-132
pubmed: 29306064
Lancet Neurol. 2008 Oct;7(10):885-92
pubmed: 18774745
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
N Engl J Med. 2016 Mar 17;374(11):1021-31
pubmed: 26890472
Lancet Neurol. 2008 Oct;7(10):893-902
pubmed: 18774746
Lancet Neurol. 2019 Apr;18(4):348-356
pubmed: 30738706
BMJ Open. 2019 Nov 11;9(11):e032140
pubmed: 31719088
Lancet. 1998 May 9;351(9113):1379-87
pubmed: 9593407
Stroke. 2004 Dec;35(12):2855-61
pubmed: 15514193
Cochrane Database Syst Rev. 2020 Feb 25;2:CD000515
pubmed: 32096559

Auteurs

Vignan Yogendrakumar (V)

Department of Medicine, Division of Neurology and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Michel Shamy (M)

Department of Medicine, Division of Neurology and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada mshamy@toh.ca.

Brian Dewar (B)

Department of Medicine, Division of Neurology and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Dean A Fergusson (DA)

Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Dar Dowlatshahi (D)

Department of Medicine, Division of Neurology and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Candyce Hamel (C)

Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Sophia Gocan (S)

Stroke Prevention Clinic, Ottawa Hospital, Ottawa, Ontario, Canada.

Mark Fedyk (M)

Bioethics Program, UC Davis Department of Medicine, Sacramento, California, USA.

Jean-Louis Mas (JL)

Universite Paris Descartes Faculte de Medecine Site Cochin, Paris, Île-de-France, France.

Peter Rothwell (P)

Service de Neurologie, Hôpital Sainte-Anne, Paris, France.

Virginia Howard (V)

The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.

Olena Bereznyakova (O)

School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH